StockData
Gelteq Ltd logo

Gelteq Ltd (GELS) stock

GELSNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through fiscal 2025, year ended Jun 30, 2025Last filing: 20-F on Nov 16, 2026Score 0/30
$0.27+0.00 (+0.37%)

Close on Nov 18, 2026Market cap $2.89MP/E –Yield –

Gelteq operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

For fiscal 2025 it was -A$5.50M.

Annual operating income

PeriodPeriod endValueChange
FY2025Jun 30, 2025-A$5.50M–
FY2024Jun 30, 2024-A$2.95M–
FY2023Jun 30, 2023-A$3.10M–

More Gelteq figures

See a number that looks wrong?